Biodexa Pharmaceuticals Plc
BDRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $20,050 | $163 | $977 | $4,655 |
| - Cash | $1,669 | $5,971 | $2,836 | $10,057 |
| + Debt | $727 | $464 | $624 | $766 |
| Enterprise Value | $19,108 | -$5,344 | -$1,235 | -$4,636 |
| Revenue | $0 | $381 | $699 | $578 |
| % Growth | -100% | -45.5% | 20.9% | – |
| Gross Profit | -$5,437 | -$3,686 | -$4,412 | -$4,076 |
| % Margin | – | -967.5% | -631.2% | -705.2% |
| EBITDA | -$9,082 | -$7,161 | -$8,261 | -$5,659 |
| % Margin | – | -1,879.5% | -1,181.8% | -979.1% |
| Net Income | -$5,729 | -$7,079 | -$7,656 | -$5,460 |
| % Margin | – | -1,858% | -1,095.3% | -944.6% |
| EPS Diluted | -115,700 | -22,900 | -494,300 | -352,500 |
| % Growth | -405.2% | 95.4% | -40.2% | – |
| Operating Cash Flow | -$12,261 | -$6,826 | -$7,048 | -$6,008 |
| Capital Expenditures | -$774 | -$263 | -$62 | -$320 |
| Free Cash Flow | -$13,035 | -$7,089 | -$7,110 | -$6,328 |